Humacyte, Inc.

NasdaqGS:HUMA Stock Report

Market Cap: US$284.3m

Humacyte Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:HUMA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Apr 25BuyUS$9,999William ScheesseleIndividual6,493US$1.54
10 Apr 25BuyUS$11,625Shamik ParikhIndividual7,500US$1.55
10 Apr 25BuyUS$30,600Dale SanderIndividual20,000US$1.53
08 Apr 25BuyUS$66,000Kathleen SebeliusIndividual50,000US$1.32
08 Apr 25BuyUS$7,740Charles GreenIndividual6,000US$1.29
07 Apr 25BuyUS$20,160Michael ConstantinoIndividual16,000US$1.26
04 Dec 24BuyUS$20,181Michael ConstantinoIndividual4,600US$4.39
20 Nov 24SellUS$6,606,799Ayabudge LLCCompany1,500,000US$4.44
19 Nov 24BuyUS$7,979Laura NiklasonIndividual1,797US$4.44

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HUMA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,389,2852.13%
Individual Insiders11,482,3487.23%
Public Companies18,312,73511.5%
Institutions58,618,58636.9%
General Public67,032,34942.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 33.1%.

Top Shareholders

Top 25 shareholders own 50.74% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Fresenius Medical Care AG
18,312,735US$32.8m0%no data
6.26%
BlackRock, Inc.
9,945,448US$17.8m20.9%no data
5.63%
Gavril Yushvaev
8,942,078US$16.0m0%no data
4.41%
The Vanguard Group, Inc.
6,999,624US$12.5m6.06%no data
2.76%
State Street Global Advisors, Inc.
4,391,111US$7.9m2.93%no data
2.16%
Centerbook Partners LP
3,430,255US$6.1m141%0.31%
1.86%
Geode Capital Management, LLC
2,948,508US$5.3m33.4%no data
1.66%
Marshall Wace LLP
2,639,194US$4.7m5,310%0.01%
1.61%
Millennium Management LLC
2,552,947US$4.6m90.5%no data
1.54%
UBS Asset Management AG
2,445,471US$4.4m46.6%no data
1.41%
Ayabudge LLC
2,241,045US$4.0m0%no data
1.26%
Woodline Partners LP
2,001,393US$3.6m-49.3%0.02%
1.14%
Rajiv Shukla
1,814,789US$3.2m0%no data
0.97%
Two Sigma Investments, LP
1,537,381US$2.8m162%no data
0.89%
Susquehanna International Group, LLP
1,416,533US$2.5m154%no data
0.86%
Morgan Stanley
1,366,834US$2.4m145%no data
0.72%
The Niklason Living Trust
1,148,240US$2.1m0%no data
0.66%
Northern Trust Global Investments
1,042,641US$1.9m12.7%no data
0.63%
Private Advisor Group, LLC
1,002,680US$1.8m51%0.01%
0.58%
Charles Schwab Investment Management, Inc.
921,873US$1.7m20.5%no data
0.53%
Medical Strategy GmbH
845,946US$1.5m0%0.09%
0.46%
LPL Financial LLC
724,800US$1.3m14.3%no data
0.41%
National Bank Investments Inc.
653,200US$1.2m-17.5%no data
0.41%
GSA Capital Partners LLP
643,744US$1.2m133%0.08%
0.39%
Citadel Advisors LLC
624,758US$1.1m-78.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/03 12:13
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Humacyte, Inc. is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Matthew MiksicBarclays
Bruce JacksonBenchmark Company
Michael GormanBTIG